More on LXEO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-139.4% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (12/14/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lexeo Therapeutics (NQ:LXEO)
Delayed: 2.64 -0.12 (4.35%)
Prev. Close $2.76  
Open$2.75 
52 Wk High$ 
52 Wk Low$ 
Day High$2.84 
Day Low$2.63 
P/E N/A  
EPS$ 
Volume2,506,682 

Friends, Peers and Foes (?): JNJ, GSGN, LRMR SLDB (more...)

Oct 13, 2026 01:38 PM Form SCHEDULE 13G Lexeo Therapeutics, Inc. Filed by: JPMORGAN CHASE & CO
Oct 8, 2026 07:00 AM Lexeo Therapeutics to Participate in the Chardan Healthcare Conference
Oct 5, 2026 05:05 AM Stifel Reiterates Buy Rating on Lexeo Therapeutics (LXEO)
Oct 1, 2026 09:01 AM Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
Sep 29, 2026 04:21 PM Form 8-K Lexeo Therapeutics, Inc. For: Sep 29
Sep 28, 2026 05:15 PM Form 4 Lexeo Therapeutics, Inc. For: Sep 24 Filed by: Bhalla Narinder Pal
Sep 28, 2026 05:15 PM Form 4 Lexeo Therapeutics, Inc. For: Sep 24 Filed by: Tamayo Louis Edward
Sep 28, 2026 05:15 PM Form 4 Lexeo Therapeutics, Inc. For: Sep 24 Filed by: Otero Jose Manuel
Sep 28, 2026 05:15 PM Form 4 Lexeo Therapeutics, Inc. For: Sep 24 Filed by: Townsend Richard Nolan
Sep 23, 2026 08:02 AM Apertura Gene Therapy grants Lexeo access to BBB-crossing capsid
View All Articles

Entities mentioned with LXEO

View All Entities